Holen Sie sich die Stockscreener-App
82.56
0.05%
0.04
Handel nachbörslich:
82.56
Schlusskurs vom Vortag:
$82.52
Offen:
$82.52
24-Stunden-Volumen:
452.29K
Relative Volume:
0.57
Marktkapitalisierung:
$4.54B
Einnahmen:
$1.43B
Nettoeinkommen (Verlust:
$107.13M
KGV:
42.62
EPS:
1.9372
Netto-Cashflow:
$161.04M
1W Leistung:
-1.27%
1M Leistung:
+5.33%
6M Leistung:
+28.18%
1J Leistung:
+76.90%
1-Tages-Spanne:
$81.50
$82.83
1-Wochen-Bereich:
$81.50
$85.27
52-Wochen-Spanne:
$41.02
$85.27
Livanova Plc Stock (LIVN) Company Profile
Firmenname
Livanova Plc
Sektor
Branche
Telefon
4402033250662
Adresse
20 EASTBOURNE TERRACE, LONDON
Compare LIVN vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
82.56 | 4.54B | 1.43B | 107.13M | 161.04M | 1.9372 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-19 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2025-10-01 | Herabstufung | Goldman | Buy → Neutral |
| 2025-05-20 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-02-26 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-10-04 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | Bestätigt | Needham | Buy |
| 2024-02-20 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-04-14 | Eingeleitet | Mizuho | Neutral |
| 2022-12-21 | Eingeleitet | Barclays | Equal Weight |
| 2022-04-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-02-24 | Hochstufung | UBS | Neutral → Buy |
| 2021-12-03 | Eingeleitet | Goldman | Buy |
| 2021-08-20 | Bestätigt | Needham | Buy |
| 2021-07-20 | Hochstufung | Needham | Hold → Buy |
| 2021-03-03 | Herabstufung | Berenberg | Buy → Hold |
| 2021-01-05 | Herabstufung | Needham | Buy → Hold |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-06-26 | Bestätigt | Needham | Buy |
| 2019-10-30 | Bestätigt | Needham | Buy |
| 2019-02-28 | Bestätigt | Needham | Buy |
| 2018-11-28 | Eingeleitet | UBS | Neutral |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-06-08 | Eingeleitet | Stifel | Buy |
| 2018-05-31 | Bestätigt | Needham | Buy |
| 2018-02-28 | Bestätigt | Needham | Buy |
Alle ansehen
Livanova Plc Aktie (LIVN) Neueste Nachrichten
World Cardiopulmonary Bypass MachineMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Price to earnings forward of LivaNova Plc – SWB:LIA - TradingView
Price to sales forward of LivaNova PLC – NASDAQ:LIVN - TradingView
LivaNova PLC balances neuromodulation growth with cardiac surgery challenges - ad-hoc-news.de
(LIVN) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Enterprise value to EBITDA forward of LivaNova PLC – NASDAQ:LIVN - TradingView
LivaNova PLC (LIVN) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
LivaNova PLC focuses on neuromodulation and cardiopulmonary solutions as investors track its Nasdaq- - ad-hoc-news.de
Enterprise value to revenue forward of LivaNova PLC – NASDAQ:LIVN - TradingView
Price to sales forward of LivaNova Plc – LSX:A14156 - TradingView
Price to book forward of LivaNova PLC – NASDAQ:LIVN - TradingView
How LivaNova’s Broad Russell Index Inclusion Will Impact LivaNova (LIVN) Investors - simplywall.st
LivaNova stock hits 52-week high at 84.3 USD - Investing.com
LivaNova Plc Change Of Registered Office - marketscreener.com
This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Sahm
Livanova stock initiated at Hold by Freedom Capital on growth outlook - Investing.com Nigeria
LivaNova Shares Positive 12-Month Results From Obstructive Sleep Apnea Study - Medical Product Outsourcing
LivaNova PLC(NasdaqGS: LIVN) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
LivaNova PLC(NasdaqGS: LIVN) added to Russell 2500 Growth Benchmark - marketscreener.com
LivaNova PLC(NasdaqGS: LIVN) added to Russell 2000 Growth Benchmark - marketscreener.com
LivaNova PLC(NasdaqGS: LIVN) added to Russell 3000E Growth Benchmark - marketscreener.com
LivaNova PLC(NasdaqGS: LIVN) added to Russell 2000 Growth-Defensive Index - marketscreener.com
LivaNova PLC(NasdaqGS: LIVN) added to Russell 3000 Growth Benchmark - marketscreener.com
(LIVN) Risk Channels and Responsive Allocation - Stock Traders Daily
LivaNova Plc Hits New 52-Week High of USD 82.62 - MarketsMojo
LivaNova PLC (LIVN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Brain Implants Market Size to Reach USD 18.39 Billion by 2035, Growing at 9.99% CAGR | SNS Insider - GlobeNewswire Inc.
Livanova PLC Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh - TradingView
LivaNova Plc Actuals & Estimates (NASDAQ:LIVN) - TradingView
LivaNova reports improved OSA outcomes with PolySync programming - MSN
LIVN Forecast — Price Target — Prediction for 2027 - TradingView
LIA Forecast — Price Target — Prediction for 2027 - TradingView
LivaNova stock hits 52-week high at 81.08 USD - Investing.com UK
LivaNova stock hits 52-week high at 81.08 USD By Investing.com - Investing.com Nigeria
How New OSA PolySync Data Could Shape LivaNova’s (LIVN) Neuromodulation Investment Narrative - Sahm
LivaNova to announce second-quarter 2026 results on Aug 5 - scanx.trade
Press Release: LivaNova to Announce Second-Quarter 2026 Results - Moomoo
Beyond the Balance Sheet: LivaNova's Q2 to Test Med-Tech's Pulse - BriefGlance
LivaNova demonstrates 84.5% cumulative response rate with PolySync programming in OSPREY study for obstructive sleep apnea - MSN
LIVN Maintained by Keybanc -- Price Target Raised to $92.00 - GuruFocus
LivaNova PLC (LIVN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
LIVN SEC FilingsLivanova Plc 10-K, 10-Q, 8-K Forms - Stock Titan
Jette Nygaard-Andersen joins LivaNova board as a new director - MSN
LivaNova PLC (LIVN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
LivaNova PLC (LIVN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
LivaNova PLC (LIVN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
LivaNova Plc Hits New 52-Week High of USD 80.77 - MarketsMojo
LivaNova PLC (LIVN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Finanzdaten der Livanova Plc-Aktie (LIVN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Livanova Plc-Aktie (LIVN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| SCHERMERHORN TODD C | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
13,105 |
| Bianchi Francesco | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
11,270 |
| Bianchi Francesco | Director |
Jun 15 '26 |
Sale |
80.19 |
1,200 |
96,228 |
9,584 |
| PODLOGAR SUSAN M | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
6,128 |
| Barry James Christopher | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
8,404 |
| Tezel Ahmet | Chief Innovation Officer |
Jun 15 '26 |
Option Exercise |
0.00 |
2,965 |
0 |
7,122 |
| KOZY WILLIAM A | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
5,681 |
0 |
38,248 |
| Enxing Seng Stacy | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
15,793 |
| Story Brooke | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
10,274 |
| Zurbay Donald | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
2,560 |
0 |
2,560 |
2.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):